Trial Evaluating Cardiovascular Outcomes With Sitagliptin
The Executive Committee for the Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin (TECOS) will accept ancillary study proposals for review. Ancillary studies may provide valuable information beyond that explored in the context of the main trial, and will promote continued academic interest in TECOS. We define an ancillary study as an investigation that is distinct from the TECOS main protocol, but uses information from TECOS participants, data, or samples collected by TECOS. Such studies may involve the acquisition of data not obtained as part of the TECOS study procedures, and may utilize information from some or all of the TECOS participants.
Please note the following specifications as you consider the submission of an ancillary study proposal:
All received ancillary study proposals will undergo an initial review by the TECOS Ancillary Studies Committee. That committee may recommend advancement of the proposal to the Executive Committee for further evaluation; request revisions of the proposed study; or reject the submission.
All ancillary studies must be reviewed and approved by the TECOS Executive Committee prior to initiation. Studies which request access to the biomarker/future use blood samples will require additional review and approval by the Biomarker Committee.
To submit an ancillary study proposal, please complete this Ancillary Study Application Form
Participation of the specified TECOS investigator will be confirmed prior to official review. Please be certain that your contact information is correct, as additional information may be requested of you during the review process. We appreciate your interest in TECOS, and look forward to receiving your proposal.